ROBIN GINYARD: Open Payments
NPI 1083186860 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $156 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $339 |
| Insulet Corporation | 1 | $169 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| SCPHARMACEUTICALS INC. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
Products named: Barostim Neo System, OMNIPOD, AMVUTTRA, FUROSCIX, CAMZYOS, Kerendia.
Industry payments across FL — which companies pay providers there.
